U.K. Health Dept. Recommends Stronger Adverse Event Reporting System In Wake Of Breast Implant Scandal
This article was originally published in The Gray Sheet
Executive Summary
Internal review finds U.K. regulators were not at fault in the PIP breast implant scandal, but recommends improvements to adverse event reporting and analysis.
You may also be interested in...
EU Parliament Considers More Stringent Medical Device Regulations
EU Parliament committee continues debate on medical device regulations, focusing on pre-market approval, scrutiny of notified bodies and post-market surveillance.
EU Device Reform Proposal Adds More Government Scrutiny, But No FDA-Like Review Body
The recommendation attracting the most concern from industry: a new Medical Device Coordination Group that would have the option to scrutinize third-party pre-market assessment reports for select devices prior to marketing.
International News In Brief
Health Canada guidance explains potential enforcement actions against noncompliant device firms. U.K. shines critical light on cosmetic procedures. More international news.